CHD

Business profile & competitive position

Church & Dwight Co., Inc. operates in the Consumer Defensive sector, specifically the Household & Personal Products industry. It develops, manufactures, and markets a wide range of consumer household and personal-care goods, alongside specialty products focused on animal nutrition, specialty chemicals, and commercial/professional cleaners. Its brand list reads like a retail-aisle tour: ARM & HAMMER, OXICLEAN, BATISTE, WATERPIK, THERABREATH, HERO, TOUCHLAND, TROJAN, FIRST RESPONSE, NAIR, ORAJEL, XTRA, and ZICAM. The company reports through three segments: Consumer Domestic, Consumer International, and the Specialty Products Division.

The Consumer Domestic segment is roughly split between household and personal care, with household products representing approximately 54% of segment net sales and personal care representing about 46% in 2025. The real driver of the franchise is a smaller set of power brands, which represented roughly 70% of consolidated net sales and profits in 2025. That concentration is the core of the investment case: a handful of large brands carry the bulk of performance. At the same time, a single customer accounted for about 23% of consolidated net sales in 2025, Walmart, and no other customer exceeded 10% over the past three years.

The margin and return data support the narrative of a brand-driven, reasonably efficient operator. Net margin is 12.0%, and ROE is 17.8%. A 17.8% ROE suggests the company earns solid returns on book equity, which is consistent with pricing power in niche household and personal-care categories. Net margin of 12.0% is solid for a diversified staples portfolio, though not exceptional for the sector’s highest-margin names. The stock’s beta is 0.47, indicating low sensitivity to broad-market swings. The main competitive read is that CHD owns a durable but concentrated brand portfolio, with both category strength and customer-concentration risk visible directly in the 10-K disclosures.

Financial posture

At the snapshot date, CHD carried a $22.5 billion market cap and traded at $95.005, below its 50-day exponential moving average of $98.52. The relative strength index was 35.8, which simply describes a stock near the lower edge of a typical two-week range rather than a directional signal. The P/E ratio was 30.5, a meaningful premium to the broader market that reflects the company’s defensive, low-beta profile.

The valuation story is one of quality at a price. A 12.0% net margin and a 17.8% ROE justify some premium relative to low-margin staples, while a beta of 0.47 fits a business that tends to generate steady, recession-resistant cash flows. At the same time, a P/E of 30.5 demands continued earnings momentum; underperformance on organic growth or margin would likely weigh on the multiple before it would threaten the dividend or the balance sheet. The current data set does not include a debt figure, so the balance-sheet assessment is limited to what is observable: a profitable, brand-heavy, low-beta consumer defensive trading at a premium multiple.

Strategic priorities & outlook

Church & Dwight’s most recent 10-K outlines a portfolio repositioning. The company has exited or is exiting Flawless, Spinbrush, Waterpik showerhead, and the VMS brands, and says it is shifting focus toward faster-growing value and premium product lines. The logic is straightforward: replace slower-growth, commoditized categories with higher-velocity segments that carry better margin and global expansion potential.

Three operational priorities stand out. First, integrate the Touchland hand-sanitizer acquisition and realize its intended contribution to sales and earnings. Second, expand the seven power brands globally, which the filing frames as having significant further international runway. Third, continue building supply-chain resilience by maintaining qualified dual sources for roughly 70% of direct materials spend. The dual-sourcing target is a direct acknowledgment of input and geopolitical risk, and it ties back to the fact that power brands already drive roughly 70% of consolidated net sales and profits. The company is clearly betting that a smaller, more focused brand set, supported by a more resilient supply chain, can deliver steadier growth than the broader legacy portfolio.

Macro & geopolitical exposure

Household & Personal Products companies sit in a defensive space, but defensive does not mean immune to macro forces. CHD’s earnings are exposed to commodity inputs such as resins, surfactants, chemicals, pulp, and packaging, plus freight and energy. Trade policy matters because tariffs or customs friction can raise the cost of imported raw materials and finished goods, particularly for the Consumer International segment. Currency translation also affects reported results: a stronger U.S. dollar reduces the dollar value of overseas revenue and profits, while a weaker dollar has the opposite effect.

Regulatory risk is structural rather than episodic. Personal care, cleaning, contraceptive, and oral-care products face FDA and FTC oversight, and changes to labeling or formulation rules can carry compliance costs. The category also competes with private-label alternatives, which gain share when household budgets tighten. Retail concentration adds another macro-adjacent pressure: when one customer accounts for about 23% of consolidated net sales, shelf-space negotiations and pricing leverage on the buy side become a persistent feature of the operating environment, independent of the economic cycle.

Recent developments

The latest news flow has been broadly positive. On 2026-09-09, Seeking Alpha published the transcript of CHD’s presentation at the Barclays 19th Annual Global Consumer Staples Conference, giving investors direct access to management messaging. On 2026-09-01, Defense World reported that Beacon Pointe Advisors LLC opened a new position worth $742,000 in the stock. On 2026-08-31, 247wallst.com included CHD in a screen of battle-tested consumer staples names that keep raising their dividends, and on the same day invezz.com ran a BofA call highlighting stocks with meaningful upside in September.

None of these items amounts to a fundamental reset of the business, but the cluster of conference exposure, new institutional buying, dividend-royalty commentary, and sell-side attention in late August and early September puts the name on more radars heading into the 2026-10-30 earnings release.

Earnings behavior & post-earnings drift

CHD has delivered a strong headline earnings record. Over the last eight reported quarters, the company beat six times, a beat rate reported as 86%, with an average earnings surprise of 5.2%. The average five-day post-earnings move across those quarters was +1.32%, classified as an “up” drift. The next report is scheduled for 2026-10-30 before the market opens, with the current consensus EPS estimate at $0.90.

The last four reports reveal why beat-rate alone can be misleading. On 2025-10-31, CHD beat by 10.1%, posting $0.81 actual against $0.736 estimate, yet the stock fell 1.61% the next day and was down 0.95% over the following five days. On 2026-01-30, a 2.9% beat ($0.86 versus $0.836) produced a 1.13% next-day gain and a 4.45% five-day gain. On 2026-05-01, a 2.0% beat ($0.95 versus $0.931) coincided with a 3.26% one-day drop and a 2.69% five-day decline. The most recent quarter, on 2026-07-31, was a 0.7% miss ($0.89 versus $0.896 estimate), but the stock still rose 1.21% the next session and 4.48% over the next five days.

The takeaway is that the post-earnings drift has not reliably continued in the direction of the surprise. An earnings beat has not consistently translated into a post-report pop and hold, and a miss has not automatically produced a durable selloff. Traders watching the 2026-10-30 print should weigh the headline number alongside guidance, margin commentary, and any update on the Touchland integration, because the +1.32% five-day average masks wide dispersion around that central tendency.

For traders who want to move beyond the numbers, this summary is only a starting point. A deeper understanding of how institutional analysts view CHD’s valuation, margin trajectory, and competitive positioning can be found in the full broker and analyst consensus report.